Amneal to Participate at Upcoming November 2023 Investor Conferences

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the below investor conferences.

Jefferies 14th Annual Global Healthcare Conference
November 14, 2023
London, UK
Presentation – 8:30 AM GMT

Piper Sandler 35th Annual Healthcare Conference
November 28, 2023
New York, New York
Presentation – 9:00 AM EST

A live webcast of the presentations will be accessible through the Investor Relations section of the Company's website at A replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit

View source version on


Anthony DiMeo
Head of Investor Relations

Source: Amneal Pharmaceuticals, Inc.

Back to news